Biotech Firm Codiak BioSciences Hits Ch. 11 With Sale Plan
Pharmaceutical company Codiak BioSciences Inc. filed for Chapter 11 protection in Delaware on Monday with $85 million in debt, saying it plans to pursue a sale of its assets through bankruptcy....To view the full article, register now.
Already a subscriber? Click here to view full article